Diagnostic Uncertainties: Chorea

Abstract Chorea is a hyperkinetic movement disorder with a multitude of potential etiologies, both acquired and inherited. Although the differential diagnosis for new-onset chorea is extensive, there are often clues in the history, exam, and basic testing that can help to narrow the options. Evaluation for treatable or reversible causes should take priority, as rapid diagnosis can lead to more favorable outcomes. While Huntington's disease is most common genetic cause of chorea, multiple phenocopies also exist and should be considered if Huntington gene testing is negative. The decision of what additional genetic testing to pursue should be based on both clinical and epidemiological factors. The following review provides an overview of the many possible etiologies as well as a practical approach for a patient presenting with new-onset chorea.

[1]  G. Pop,et al.  Clinical and Radiological Follow-Up of a Pfizer-BioNTech COVID-19 Vaccine-Induced Hemichorea-Hemiballismus , 2022, Tremor and other hyperkinetic movements.

[2]  R. Walker,et al.  One Side of the Story; Clues to Etiology in Patients with Asymmetric Chorea , 2022, Tremor and other hyperkinetic movements.

[3]  A. Słowik,et al.  Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report. , 2022, Neurologia i neurochirurgia polska.

[4]  S. Schneider,et al.  Relationship between COVID‐19 and movement disorders: A narrative review , 2021, European journal of neurology.

[5]  S. Najjar,et al.  Case Report: HSV-2 Encephalitis Presenting With Chorea; Effects of Infection Alone or Combination of Infection and Autoimmunity? , 2021, Frontiers in Neurology.

[6]  A. U. Haq,et al.  The Spectrum of Movement Disorders in Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Both in Children and Adults: An Experience From a Single Tertiary Care Center , 2021, Cureus.

[7]  J. Baehring,et al.  Choreoathetosis in the Setting of Human Herpesvirus-6 Infection in a Transplant Recipient , 2021, Tremor and other hyperkinetic movements.

[8]  S. de Bot,et al.  Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review , 2021, Movement disorders : official journal of the Movement Disorder Society.

[9]  B. Teixeira,et al.  Choreoathetosis in Moyamoya Disease in Childhood. , 2021, World neurosurgery.

[10]  M. King,et al.  Paroxysmal Movement Disorders , 2021, Frontiers in Neurology.

[11]  Jannis Achenbach,et al.  Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years , 2021, Brain sciences.

[12]  A. Pisani,et al.  Adult-onset sporadic chorea: real-world data from a single-centre retrospective study , 2021, Neurological Sciences.

[13]  J. Alberch,et al.  Proceedings of the Tenth International Meeting on Neuroacanthocytosis Syndromes , 2021, Tremor and other hyperkinetic movements.

[14]  S. Tabrizi,et al.  Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions , 2021, Neurology: Genetics.

[15]  J. Infante,et al.  Amphetamine-induced hemichorea , 2021, Neurological Sciences.

[16]  J. Youn,et al.  Risk factors and prognosis of adult-onset post-pump chorea , 2021, Journal of the Neurological Sciences.

[17]  E. Dardiotis,et al.  Fahr’s syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases , 2021, Clinical Neurology and Neurosurgery.

[18]  R. Jamora,et al.  Hemichorea-Hemiballismus as a Presentation of Cerebritis from Intracranial Toxoplasmosis and Tuberculosis , 2021, Tremor and other hyperkinetic movements.

[19]  J. Benito-León,et al.  Hypermanganesemia Induced Chorea and Cognitive Decline in a Tea Seller , 2020, Tremor and other hyperkinetic movements.

[20]  H. Shill,et al.  Chorea in IgLON5‐Mediated Autoimmune Encephalitis , 2020, Movement disorders clinical practice.

[21]  F. Cardoso,et al.  Chorea in children: etiology, diagnostic approach and management , 2020, Journal of Neural Transmission.

[22]  R. Walker,et al.  Treatment of Secondary Chorea: A Review of the Current Literature , 2020, Tremor and other hyperkinetic movements.

[23]  Chiou-Lian Lai,et al.  Long-term overdose of cold syrup induced hemichorea-hemiballismus , 2020, Neurological Sciences.

[24]  I. Savitcheva,et al.  Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations , 2020, Neurology: Genetics.

[25]  A. Lang,et al.  Movement Disorders Due to Selective Basal Ganglia Lesions with Uremia , 2020, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[26]  Cheuk-Kwan Sun,et al.  “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes , 2020, Scientific Reports.

[27]  J. Miyasaki,et al.  Movement disorders in pregnancy. , 2020, Handbook of clinical neurology.

[28]  K. Heo,et al.  A case of dyskinesia after levetiracetam administration , 2019, BMC Neurology.

[29]  S. Ravat,et al.  Adult-Onset Isolated Hemichorea Revealing Iatrogenic Hypoparathyroidism and Bilateral Basal Ganglia Calcification , 2019, Annals of Indian Academy of Neurology.

[30]  C. Lucchinetti,et al.  Phosphodiesterase 10A IgG , 2019, Neurology.

[31]  P. Hanna,et al.  Pure Cortical Stroke Causing Hemichorea-Hemiballismus. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[32]  A. Dey,et al.  Reversible chorea secondary to uremia in an older adult , 2019, Aging medicine (Milton (N.S.W)).

[33]  A. Guzzetta,et al.  A Not So Benign Family Pedigree With Hereditary Chorea: A Broader Phenotypic Expression or Additional Picture? , 2019, Child neurology open.

[34]  J. Gurumukhani,et al.  Phenytoin Induced Chorea: A Rare Adverse Effect of the Drug. , 2019, Current drug safety.

[35]  Paola Giunti,et al.  Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17 , 2018, Front. Cell. Neurosci..

[36]  J. Waugh,et al.  Inherited and Acquired Choreas. , 2018, Seminars in pediatric neurology.

[37]  G. Zanusso,et al.  Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction , 2018, Neurological Sciences.

[38]  J. Jankovic,et al.  Autoimmune and paraneoplastic movement disorders: An update , 2018, Journal of the Neurological Sciences.

[39]  C. Ryan,et al.  Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. , 2017, Parkinsonism & related disorders.

[40]  A. Danek,et al.  Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome. , 2017, European journal of medical genetics.

[41]  Mark C. Stahl,et al.  Persistent Hemichorea and Caudate Atrophy in Untreated Diabetic Striatopathy: A Case Report , 2017, Case Reports in Neurology.

[42]  E. Gatto,et al.  Sertraline-induced Hemichorea , 2017, Tremor and other hyperkinetic movements.

[43]  N. Krishnan,et al.  Cracking the Crack Dance: A Case Report on Cocane-Induced Choreoathetosis , 2017 .

[44]  J. Ferreira,et al.  Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort , 2017, Movement disorders clinical practice.

[45]  R. Djaldetti,et al.  Anti-Yo, chorea and hemiballismus: A case report , 2017, Journal of Clinical Neuroscience.

[46]  A. Bhansali,et al.  "Diabetic striatopathy" and ketoacidosis: Report of two cases and review of literature. , 2017, Diabetes research and clinical practice.

[47]  Mark Obermann,et al.  HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment , 2017, Journal of Neurology.

[48]  A. Frigo,et al.  Herpes simplex virus‐induced anti‐N‐methyl‐d‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases , 2017, Developmental medicine and child neurology.

[49]  J. Pedroso,et al.  Dentatorubro-Pallidoluysian Atrophy (DRPLA) among 700 Families with Ataxia in Brazil , 2017, The Cerebellum.

[50]  E. Newman,et al.  Hereditary chorea – what else to consider when the Huntington's disease genetics test is negative? , 2017, Acta neurologica Scandinavica.

[51]  R. Margolis,et al.  A Systematic Review of the Huntington Disease-Like 2 Phenotype. , 2017, Journal of Huntington's disease.

[52]  Francisco Cardoso Autoimmune choreas , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[53]  F. Cardoso,et al.  Abnormal eye movements in three types of chorea , 2016, Arquivos de Neuro-Psiquiatria.

[54]  C. Cosentino,et al.  Hemichorea/Hemiballism Associated with Hyperglycemia: Report of 20 Cases , 2016, Tremor and other hyperkinetic movements.

[55]  Simon E. Laganiere,et al.  Network localization of hemichorea-hemiballismus , 2016, Neurology.

[56]  D. Grozeva,et al.  Phenotypic insights into ADCY5‐associated disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[57]  C. Korff,et al.  Diabetic Striatopathy in Childhood: A Case Report , 2016, Pediatrics.

[58]  M. Jog,et al.  Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management , 2016, Tremor and other hyperkinetic movements.

[59]  Sorab Gupta,et al.  A Case Report of Chorea Associated with Hyperthyroidism. , 2016, Journal of clinical and diagnostic research : JCDR.

[60]  P. Santens,et al.  Adult-onset Sydenham’s chorea or drug-induced movement disorder? A case report , 2016, Acta Neurologica Belgica.

[61]  V. Fung,et al.  ADCY5 identified as a novel cause of benign hereditary chorea , 2015, Movement disorders : official journal of the Movement Disorder Society.

[62]  C. Ross,et al.  Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[63]  N. Quinn,et al.  ADCY5 mutations are another cause of benign hereditary chorea , 2015, Neurology.

[64]  Lu Wang,et al.  Chorea associated with nonketotic hyperglycemia: An uncommon patient with bilateral movements , 2015, Journal of Clinical Neuroscience.

[65]  Y. Tokuda,et al.  Drug-induced hemichorea , 2015, BMJ Case Reports.

[66]  S. Chung,et al.  Chorea due to diabetic hyperglycemia and uremia: Distinct clinical and imaging features , 2015, Movement disorders : official journal of the Movement Disorder Society.

[67]  T. Babu,et al.  Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease , 2015, Indian journal of pharmacology.

[68]  B. Jabbari,et al.  Chorea Associated with High Titers of Antiphospholipid Antibodies in the Absence of Antiphospholipid Antibody Syndrome , 2015, Tremor and other hyperkinetic movements.

[69]  Kara M. Smith,et al.  Sex differences in Parkinson's disease and other movement disorders , 2014, Experimental Neurology.

[70]  K. Bhatia,et al.  Paroxysmal dyskinesias revisited: A review of 500 genetically proven cases and a new classification , 2014, Movement disorders : official journal of the Movement Disorder Society.

[71]  G. Jackson,et al.  Hemichorea in a patient with diabetic ketoacidosis , 2014, Journal of the Neurological Sciences.

[72]  R. Woltjer,et al.  Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of γ-aminobutyric acid type B receptor autoimmunity. , 2014, JAMA neurology.

[73]  P. McColgan,et al.  C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies , 2014, Neurology.

[74]  A. Rosser,et al.  Hypercalcaemia mimicking Huntington's disease: lessons learned from delayed diagnosis. , 2014, The journal of the Royal College of Physicians of Edinburgh.

[75]  P. Svenningsson,et al.  Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation , 2013, Prion.

[76]  A. Cheung,et al.  Susceptibility Weighted Imaging as a Useful Imaging Adjunct in Hemichorea Hyperglycaemia , 2013, Case reports in radiology.

[77]  J. Jankovic,et al.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome , 2013, Journal of Neural Transmission.

[78]  J. Matsumoto,et al.  Autoimmune chorea in adults , 2013, Neurology.

[79]  L. Carmant,et al.  Rising Serum Thyroxine Levels and Chorea in Graves’ Disease , 2013, Pediatrics.

[80]  P. Chung,et al.  Exacerbation of idiopathic paroxysmal kinesigenic dyskinesia in remission state caused by secondary hypoparathyroidism with hypocalcemia after thyroidectomy: Evidence for ion channelopathy , 2012, Brain and Development.

[81]  F. Cardoso,et al.  Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: A pilot study to investigate the potential of SC antibodies to increase dopaminergic activity , 2012, Neuroscience Letters.

[82]  B. Cheeran,et al.  Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis , 2012, Neurology.

[83]  F. Cardoso,et al.  Pregnancy in patients with Sydenham's Chorea. , 2012, Parkinsonism & related disorders.

[84]  Hans H. Jung,et al.  McLeod neuroacanthocytosis syndrome , 2012 .

[85]  E. Anagnostou,et al.  Hypoglycemia-induced hemichorea in a patient with Fahr’s syndrome , 2012, Neurological Sciences.

[86]  Catherine H. Yu,et al.  Chorea--an unusual manifestation in a woman recovering from myxedema coma. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[87]  D. Tarsy,et al.  Spinocerebellar Ataxia-Type 17 , 2012 .

[88]  G. Kleiner-Fisman Benign hereditary chorea. , 2020, Handbook of clinical neurology.

[89]  D. Burn,et al.  Hyperthyroid chorea. , 2011, Handbook of clinical neurology.

[90]  W. Weiner,et al.  Chorea gravidarum. , 2011, Handbook of clinical neurology.

[91]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[92]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[93]  M. Weinberger,et al.  Benign hereditary chorea: an update. , 2011, Parkinsonism & related disorders.

[94]  J. Honnorat,et al.  Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience , 2011, Journal of Neurology.

[95]  A. Baraka,et al.  The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease. , 2011, Life sciences.

[96]  R. Walker Differential Diagnosis of Chorea , 2011, Current neurology and neuroscience reports.

[97]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[98]  J. Zijlmans Vascular chorea in adults and children. , 2011, Handbook of clinical neurology.

[99]  M. Lew,et al.  Polycythemia and chorea. , 2011, Handbook of clinical neurology.

[100]  J. Miyasaki Chorea caused by toxins. , 2011, Handbook of clinical neurology.

[101]  J. Sanchez-Ramos,et al.  Hyperkinetic movement disorders associated with HIV and other viral infections. , 2011, Handbook of clinical neurology.

[102]  F. Cardoso Sydenham's chorea. , 2011, Handbook of clinical neurology.

[103]  R. Will,et al.  Diagnosing variant Creutzfeldt–Jakob disease: a retrospective analysis of the first 150 cases in the UK , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[104]  Au Wing Lok,et al.  Valproate‐induced reversible hemichorea , 2010, Movement disorders : official journal of the Movement Disorder Society.

[105]  Wei Zhang,et al.  Meige's syndrome and hemichorea associated with hyperthyroidism , 2010, Journal of the Neurological Sciences.

[106]  Sung-Woo Chung,et al.  Chorea as the first neurological symptom of delayed encephalopathy after carbon monoxide intoxication. , 2010, Internal medicine.

[107]  D. Kondziella,et al.  Choreathetosis due to abuse of levothyroxine , 2009, Journal of Neurology.

[108]  Nick C Fox,et al.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.

[109]  R. Tampi,et al.  Chorea associated with gabapentin use in an elderly man. , 2009, The American journal of geriatric pharmacotherapy.

[110]  D. Gilbert Acute and chronic chorea in childhood. , 2009, Seminars in pediatric neurology.

[111]  S. Ozben,et al.  Chorea as the presenting feature of neurosyphilis. , 2009, Neurology India.

[112]  B. Thomas,et al.  Concepts and controversies in nonketotic hyperglycemia‐induced hemichorea: Further evidence from susceptibility‐weighted MR imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[113]  A. Destée,et al.  Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation , 2008, Brain : a journal of neurology.

[114]  B. Radanović,et al.  Pharmacologic side effects and/or neurologic disorder: case report. , 2009, Psychiatria Danubina.

[115]  Kwang-Soo Lee,et al.  No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI , 2008, Neurological Sciences.

[116]  H. Shang,et al.  The Neurological Presentation of Ceruloplasmin Gene Mutations , 2008, European Neurology.

[117]  D. Birchall,et al.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation , 2008, Neurology.

[118]  M. Rossor,et al.  Huntington's disease phenocopies are clinically and genetically heterogeneous , 2008, Movement disorders : official journal of the Movement Disorder Society.

[119]  Michael A. Miller,et al.  Choreiform Dyskinesia Following Isolated Lamotrigine Overdose , 2008, Journal of child neurology.

[120]  M. Lai,et al.  Hemichorea associated with gabapentin therapy with hypoperfusion in contralateral basal ganglion – a case of a paraplegic patient with neuropathic pain , 2008, Journal of clinical pharmacy and therapeutics.

[121]  L. Dure,et al.  Nutritional Vitamin D Deficiency Presenting as Hemichorea , 2007, Journal of child neurology.

[122]  D. Birchall,et al.  Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. , 2006, Brain : a journal of neurology.

[123]  F. Aichner,et al.  Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment , 2006, Movement disorders : official journal of the Movement Disorder Society.

[124]  P. Bauer,et al.  Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown cause , 2006, Movement disorders : official journal of the Movement Disorder Society.

[125]  C. Sandborg,et al.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. , 2006, The Journal of rheumatology.

[126]  E. Benarroch,et al.  Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. , 2006, Mayo Clinic proceedings.

[127]  P. Gonzalez-Alegre,et al.  Clinical Characteristics of Childhood-Onset (Juvenile) Huntington Disease: Report of 12 Patients and Review of the Literature , 2006, Journal of child neurology.

[128]  J. Guimarães,et al.  Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree , 2006, Clinical practice and epidemiology in mental health : CP & EMH.

[129]  A. Brice,et al.  Spinocerebellar Ataxia 17 and Huntington's Disease-like 4 , 2006 .

[130]  A. Teixeira,et al.  Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy. , 2005, Parkinsonism & related disorders.

[131]  A. Teixeira,et al.  Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea , 2005, Neurology.

[132]  J. V. van Gerpen,et al.  Ciprofloxacin‐induced chorea , 2005, Movement disorders : official journal of the Movement Disorder Society.

[133]  Annette Lee,et al.  Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .

[134]  J. Mysore,et al.  Huntington's disease–like 2 (HDL2) in North America and Japan , 2004, Annals of neurology.

[135]  F. Alarcón,et al.  Post-stroke movement disorders: report of 56 patients , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[136]  R. Bhidayasiri,et al.  Chorea and related disorders , 2004, Postgraduate Medical Journal.

[137]  I. Korn‐Lubetzki,et al.  Recurrence of Sydenham chorea: implications for pathogenesis. , 2004, Archives of neurology.

[138]  J. Gracies,et al.  Movement disorders and AIDS: a review. , 2004, Parkinsonism & related disorders.

[139]  S. Chung,et al.  Hemichorea after stroke: Clinical-radiological correlation , 2004, Journal of Neurology.

[140]  Hung-Chou Kuo,et al.  Delayed encephalopathy after carbon monoxide intoxication--long-term prognosis and correlation of clinical manifestations and neuroimages. , 2004, Acta neurologica Taiwanica.

[141]  E. Broussolle,et al.  Chorea after Cardiopulmonary Bypass , 2004, European Neurology.

[142]  R. Cruciani,et al.  Choreiform movements after a single dose of methadone. , 2003, Journal of pain and symptom management.

[143]  A. Durr,et al.  Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. , 2003, Archives of neurology.

[144]  Shih-Jung Cheng,et al.  The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients , 2003, Journal of Neurology.

[145]  M. Volontè,et al.  Cause and course in a series of patients with sporadic chorea , 2003, Journal of Neurology.

[146]  A. Nath Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. , 2002, The Journal of infectious diseases.

[147]  G. Fuller,et al.  Paraneoplastic chorea: case study with autopsy confirmation. , 2002, Neuro-oncology.

[148]  B. D. de Vries,et al.  Mutations in TITF-1 are associated with benign hereditary chorea. , 2002, Human molecular genetics.

[149]  J. Piette,et al.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. , 2002, Arthritis and rheumatism.

[150]  C A Ross,et al.  A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion , 2001, Annals of neurology.

[151]  M. Tennison,et al.  Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction? , 2001, Seizure.

[152]  A. Monaco,et al.  McLeod neuroacanthocytosis: Genotype and phenotype , 2001, Annals of neurology.

[153]  M. Burmeister,et al.  Interpretation of linkage data for a Huntington-like disorder mapping to 4p15.3. , 2000, American journal of human genetics.

[154]  R. Verdugo,et al.  Abnormal movements in complex regional pain syndrome: Assessment of their nature , 2000, Muscle & nerve.

[155]  M Kambouris,et al.  Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. , 2000, American journal of human genetics.

[156]  F. Cardoso,et al.  Persistent Sydenham's chorea , 1999, Movement disorders : official journal of the Movement Disorder Society.

[157]  J. Chapman,et al.  Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes , 1999, Lupus.

[158]  U. Bonnet,et al.  Choreoathetoid Movements Associated with Rapid Adjustment to Methadone , 1998, Pharmacopsychiatry.

[159]  M. Zeidler,et al.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests , 1997, The Lancet.

[160]  F. Cardoso,et al.  Chorea in fifty consecutive patients with rheumatic fever , 1997, Movement disorders : official journal of the Movement Disorder Society.

[161]  N. Malats,et al.  Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[162]  Á. Chamorro,et al.  Chorea in the Antiphospholipid Syndrome: Clinical, Radiologic, and Immunologic Characteristics of 50 Patients from Our Clinics and the Recent Literature , 1997, Medicine.

[163]  J. Bogousslavsky,et al.  Hyperkinetic movement disorders during and after acute stroke: The Lausanne Stroke Registry , 1997, Journal of the Neurological Sciences.

[164]  M. S. Lee,et al.  Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings , 1994, Movement disorders : official journal of the Movement Disorder Society.

[165]  J. Aldag,et al.  A 10‐year experience with postpump chorea , 1993, Annals of neurology.

[166]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[167]  R. Darnell,et al.  Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies , 1993, The Lancet.

[168]  M. Baba,et al.  Persistent hemichorea associated with thyrotoxicosis. , 1992, Internal medicine.

[169]  H. Vitzthum,et al.  [Delayed encephalopathy]. , 1986, Zentralblatt fur Neurochirurgie.

[170]  Joseph B. Martin Huntington's disease , 1984, Neurology.

[171]  R. Gil,et al.  [Morvan's fibrillary chorea and acrodynic syndrome following mercury treatment]. , 1984, Revue neurologique.

[172]  S. Oyanagi,et al.  Familial myoclonus epilepsy and choreoathetosis , 1982, Neurology.

[173]  N. Tannir,et al.  Rapid correction by 1-α-hydroxycholecalciferol of hemichorea in surgical hypoparathyroidism , 1982 .

[174]  P. Howdle,et al.  Hypocalcaemic chorea secondary to malabsorption. , 1979, Postgraduate medical journal.

[175]  J. F. Patterson Chronic Thallitoxicosis: Treatment of the Choreiform Sequelae , 1975, Southern medical journal.

[176]  J. Martell,et al.  Chorea , 1954, The Canadian nurse.